Cipher Pharmaceuticals Inc.
CPHRF
$10.44
$0.242.35%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -4.10% | 11.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.10% | 11.33% | |||
| Cost of Revenue | -6.00% | -13.23% | |||
| Gross Profit | -3.66% | 19.07% | |||
| SG&A Expenses | -9.08% | -15.30% | |||
| Depreciation & Amortization | -0.55% | -0.82% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.33% | -12.10% | |||
| Operating Income | -0.34% | 101.74% | |||
| Income Before Tax | -33.52% | 239.43% | |||
| Income Tax Expenses | -342.77% | 169.47% | |||
| Earnings from Continuing Operations | -6.65% | 124.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.65% | 124.58% | |||
| EBIT | -0.34% | 101.74% | |||
| EBITDA | -0.43% | 58.24% | |||
| EPS Basic | -4.83% | 122.24% | |||
| Normalized Basic EPS | -34.26% | 214.43% | |||
| EPS Diluted | -4.55% | 120.00% | |||
| Normalized Diluted EPS | -34.17% | 213.93% | |||
| Average Basic Shares Outstanding | -1.91% | 1.00% | |||
| Average Diluted Shares Outstanding | -2.11% | 1.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||